Cancer concept (Photo: Shutterstock)

A bipartisan group of lawmakers last week reintroduced legislation to encourage innovative drug development targeting the most threatening infections, improve the appropriate use of antibiotics and ensure domestic availability of antibiotics when needed. The legislation is called the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.

“Right now, we don’t have the tools to address the threat posed by antimicrobial resistance — and infectious disease experts are warning us that it will only get worse,” said U.S. Sen. Michael Bennet, D-Colo., who cosponsored the bill. “The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next-generation antibiotics and save lives. We can’t sit on our hands as this public health crisis arrives — we have to act now.”

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.